Not exact matches
Better yet, a
clinical review of nearly 150 studies
found that people with strong social ties had a 50 percent better chance of survival, regardless of age, sex, health status, and cause of
death, than those with weaker ties.
Lo's team set out to
find ways to further weaken the tumors, since the drug addiction response (which can range from a mere slow down of the cancer's growth rate to cancer cell
death), can be used to improve
clinical outcomes.
A comprehensive analysis of the study's results — published in June 1 online edition of the New England Journal of Medicine and to be presented at the American Society of
Clinical Oncology (ASCO) annual meeting in Chicago —
found participants treated with enzalutamide saw an 81 percent reduction in the risk the cancer would progress and a 29 percent reduction in the risk of
death.
In a new study, a hospital surveillance program focusing on reducing the risks of sepsis, known as the two - stage
Clinical Decision Support (CDS) system, was
found to reduce the risk of adverse outcomes, such as
death and hospice discharge for sepsis patients, by 30 % over the course of one year.
The researchers defined adverse outcomes as the
death of the fetus or a live infant with severe abnormal
clinical or brain imaging
findings.
The invocation of cell
death in this disorder would explain the
clinical feature, the small heads caused by loss of nerve cells in the brain, the team
found.
In their new study, they extend these
findings by showing that Eritoran — a synthetic inhibitor of TLR4, originally developed by Eisai Inc. for treatment of sepsis — improved
clinical symptoms and prevented
death when administered up to six days after infection with the influenza virus.
Raleigh's team
found that a gene named FOXM1 was at the heart of aggressive meningioma growth, and a signpost of subsequently poor
clinical outcomes, including
death.
Amyotrophic lateral sclerosis (ALS) is caused by massive motor neuron
death and, as pre ‐
clinical data have failed to translate into better outcomes in
clinical trials [1], stem cell trials have been conducted to
find alternative therapeutic solutions.
A potential explanation for the secular trend may be that while improved treatment for cardiovascular risk factors or complicating diseases has reduced mortality in all weight classes, the effects may have been greater at higher BMI levels than at lower BMI levels.12 Because obesity is a causal risk factor for hypertension, diabetes, cardiovascular disease, and dyslipidemia,15,19 - 22 obese individuals may have had a higher selective decrease in mortality.18 Indirect evidence of this effect is seen in the
findings as the
deaths occur at similar time periods in the 3 cohorts, but cohorts recruited at later periods have an increase in the BMI associated with the lowest mortality, possibly suggesting a period effect related to changes in
clinical practice, such as improved treatments, or general public health status, such as decreased smoking or increased physical activity.
Yet another study, a meta - analysis of seven
clinical trials involving about 1,150 patients with bleeding ulcers,
found that higher doses of proton pump inhibitors did not reduce the risk of additional bleeding, need for surgery, or
death more effectively than lower doses did.
A study published in August 2010 in theAmerican Journal of
Clinical Nutrition
found that if saturated fat in the diet is too low, it can lead to an increased risk of
death from stroke.
In fact, a study published in 2017 in The American Journal of
Clinical Nutrition
found that people who ate fried potatoes twice a week saw an increased risk of
death.
«These
findings mean that physicians should try to control a patient's heart rate by using alternatives as a first line, such as beta - blockers or calcium blockers; if digoxin is used, use a low dose with careful
clinical follow - up, evaluate potential drug interactions when starting new medications, and monitor digoxin levels,» the authors said «Patients should be aware of potential toxicity and see their physicians immediately in specific
clinical situations, for instance if they experience palpitations or syncope (fainting), as those may precede arrhythmic
death,» they added.
These women also had a 22 percent higher overall
death rate and a 25 percent higher risk of dying from cancer, according to
findings published in the Journal of
Clinical Endocrinology and Metabolism.